|
Tenofovir amibufenamide vs Vemlidy
|
|
5
|
810
|
18 April 2024
|
|
Young Investigator Awards for Hepatitis Research
|
|
1
|
224
|
6 April 2024
|
|
Position Available: Viral Hepatitis Peer Worker (Lived Experience)
|
|
0
|
232
|
2 April 2024
|
|
Exploratory Hepatitis B dataset: Encouraging new hypotheses
|
|
4
|
480
|
31 March 2024
|
|
VH2024: Abstract & Scholarship Opportunities
|
|
0
|
184
|
11 March 2024
|
|
Health & Law Project
|
|
1
|
207
|
9 March 2024
|
|
Community & Lived Experience Scholarships for VH2024
|
|
3
|
320
|
5 March 2024
|
|
Positions Available at Hepatitis NSW
|
|
0
|
186
|
23 February 2024
|
|
Position Available: Casual Multicultural Liver Health Worker
|
|
1
|
211
|
1 March 2024
|
|
Recent HBV studies
|
|
8
|
510
|
7 January 2024
|
|
VIR-3434 Phase 1-study made by Vir Biotechnology
|
|
28
|
2932
|
21 December 2023
|
|
Hep Q & A Night
|
|
1
|
271
|
4 December 2023
|
|
Inaugural Meeting Progress on Hepatitis B Elimination in Canada
|
|
1
|
569
|
24 September 2023
|
|
Ab-729 Trial, should I join?
|
|
81
|
3698
|
5 September 2023
|
|
HBV International Meeting 4th Annual Community Forum
|
|
5
|
447
|
2 September 2023
|
|
NMN supplement investigated as a potential cure - “Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis B”
|
|
14
|
1622
|
19 August 2023
|
|
New treatment of HepB maybe ? AGT
|
|
2
|
585
|
31 July 2023
|
|
Brii Bio results
|
|
2
|
409
|
27 June 2023
|
|
Vaccitech - HBV002 Study
|
|
4
|
608
|
24 June 2023
|
|
Arbutus - AB-729 rnai, phase2 results
|
|
1
|
451
|
23 June 2023
|
|
Community Scholarships for HIV Coinfection + VH Elimination Conference 2023
|
|
2
|
346
|
10 June 2023
|
|
HepBFoundation Clinical Trials Finder
|
|
0
|
326
|
8 June 2023
|
|
SCG Cell Therapy to Present Late-Breaking Data
|
|
10
|
819
|
8 June 2023
|
|
Hepatitis B Voices Australia - New advocacy group
|
|
14
|
1129
|
2 June 2023
|
|
Cold and blue hands
|
|
12
|
3329
|
2 May 2023
|
|
Evaluation of Hepatitis B Virus (HBV) DNA Test as Point of Care Tool (HBVPOCT)
|
|
0
|
449
|
24 April 2023
|
|
Nucs off functional cure
|
|
1
|
614
|
4 April 2023
|
|
Discovery of a first-in-class orally available HBV cccDNA inhibitor
|
|
4
|
716
|
4 April 2023
|
|
Lived Experience Treatment Preferences Survey
|
|
1
|
488
|
8 March 2023
|
|
Call for research participants ($50 reimbursement for time)
|
|
6
|
697
|
23 February 2023
|